The future of biotech innovation and entrepreneurship belongs to the institutions that can work collaboratively within a network of stakeholders, bridging the cultural and logistical divides between academia and industry to place the right asset with the right commercial development partner at the right time – ultimately leading to positive impact on patient care, well-being and outcomes.
Weill Cornell Medicine Enterprise Innovation accelerates the translation of scientific innovation now and incubates ideas for the future – we ensure biotech innovation is brought to market efficiently by proactively working with faculty and trainees to nurture promising ideas and secure commercial development collaborations. Through education, engagement and mentorship, Weill Cornell Medicine Enterprise Innovation provides a clear and realistic picture of the commercialization process for the institution’s faculty and trainees.
Click the link below to learn more about the path from inception to commercialization and how we can support your journey from beginning to end.
